[ RECIPIENT ENTITY RECORD ]

DICE Therapeutics

VERIFIED NODE ID: 001721 · dice-therapeutics
R TARGET NODE — CAPITAL RECIPIENT
DICE Therapeutics
Company United States
Recipient Type
Company
Primary Jurisdiction
United States
Registration Status
ACTIVE
Entity Intelligence [ R ]
Legal Name DICE Therapeutics
Entity Type Company
Jurisdiction United States
Recipient Intelligence Summary

DICE Therapeutics is a biotechnology company focused on developing oral versions of established biologic medicines for chronic immunological conditions. Based in California, the company utilizes a unique chemical platform for drug discovery. It was a significant destination for institutional healthcare capital through a high-value pharmaceutical acquisition.

Capital Influx Log (Transactions)
Date Type Amount
22 May 2026 EQUITY $2.4B